enVVeno Medical (NVNO) Long-Term Investments (2022 - 2026)

enVVeno Medical has reported Long-Term Investments for 5 years, with the latest figure at $24.9 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments fell 35.99% year-over-year to $24.9 million; the trailing twelve-month figure through Mar 2026 stood at $24.9 million (down 35.99% YoY), and the FY2025 full-year result was $25.1 million, down 39.37% from the prior year.
• Long-Term Investments for Q1 2026 stood at $24.9 million, down from $25.1 million in the prior quarter.
• The five-year high for Long-Term Investments was $48.4 million in Q3 2024, with the low at $2.4 million in Q3 2022.
• Average Long-Term Investments over 5 years is $33.5 million, with a median of $36.6 million recorded in 2022.
• Year-over-year, Long-Term Investments soared 56.4% in 2024 and slumped 39.37% in 2025.
• Tracing NVNO's Long-Term Investments over 5 years: stood at $34.5 million in 2022, then increased by 24.06% to $42.8 million in 2023, then declined by 3.27% to $41.4 million in 2024, then sank by 39.37% to $25.1 million in 2025, then dropped by 0.8% to $24.9 million in 2026.
• The last three Long-Term Investments figures came in at $24.9 million (Q1 2026), $25.1 million (Q4 2025), and $31.0 million (Q3 2025), per Business Quant data.

Peer Comparison